Down syndrome: searching for the genetic culprits
Open Access
- 1 September 2011
- journal article
- research article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 4 (5) , 586-595
Abstract
Down syndrome (DS) is caused by trisomy of human chromosome 21 (Hsa21) and results in a large number of phenotypes, including learning difficulties, cardiac defects, distinguishing facial features and leukaemia. These are likely to result from an increased dosage of one or more of the ∼310 genes present on Hsa21. The identification of these dosage-sensitive genes has become a major focus in DS research because it is essential for a full understanding of the molecular mechanisms underlying pathology, and might eventually lead to more effective therapy. The search for these dosage-sensitive genes is being carried out using both human and mouse genetics. Studies of humans with partial trisomy of Hsa21 have identified regions of this chromosome that contribute to different phenotypes. In addition, novel engineered mouse models are being used to map the location of dosage-sensitive genes, which, in a few cases, has led to the identification of individual genes that are causative for certain phenotypes. These studies have revealed a complex genetic interplay, showing that the diverse DS phenotypes are likely to be caused by increased copies of many genes, with individual genes contributing in different proportions to the variance in different aspects of the pathology.Keywords
This publication has 108 references indexed in Scilit:
- The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndromeBehavioural Brain Research, 2011
- Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in miceBrain Research, 2010
- Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndromeGenetic Epidemiology, 2010
- Tumour angiogenesis is reduced in the Tc1 mouse model of Down’s syndromeNature, 2010
- Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic “Down syndrome” miceAmerican Journal of Medical Genetics Part A, 2009
- Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1Nature, 2009
- Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21European Journal of Human Genetics, 2008
- Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down SyndromeThe American Journal of Human Genetics, 2008
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991